Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tnib 11mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Micro Labs Ltd

Salt Composition

Tofacitinib (11mg)

Overview Tnib 11mg Tablet ER

Extended-release Tnib 11mg tablets treat moderate-to-severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. This medication alleviates joint pain, tenderness, and swelling by suppressing inflammation, and helps retard the progression of bone and joint deterioration. Tnib 11mg ER may be administered alone or in conjunction with other drugs. These tablets can be ingested with or without food, ideally at the same time daily. Dosage is determined by your health status and other medications. Always follow your physician's instructions; discontinue use only under their guidance, as abrupt cessation may exacerbate your condition. Common side effects include upper respiratory infections, headaches, diarrhea, and nasopharyngitis. Rarer, potentially serious adverse reactions, such as blood clots and gastrointestinal perforations, necessitate immediate medical attention. Report any concerns regarding side effects to your doctor. Pre-treatment blood tests are often required, and the medication should not be initiated if you have an active infection. Consult your physician prior to commencing treatment if you have a history of tuberculosis, herpes zoster, hepatic or renal impairment, hepatitis B or C, or pulmonary or venous thromboembolism. Tnib 11mg ER increases susceptibility to infections and can worsen existing ones; avoid contact with contagious individuals (e.g., those with influenza, measles, or chickenpox). This medication is contraindicated for children under 18 and pregnant or breastfeeding individuals, except when the physician deems the benefits outweigh the potential risks. Regular check-ups with your doctor may be necessary.

Uses of Tnib 11mg Tablet ER

Management of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.

Major Benefits of Tnib 11mg Tablet ER:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tnib 11mg Extended-Release Tablets can be consumed with or without food, though consistent timing is recommended.

Common Side effects of Tnib 11mg Tablet ER:

  • Upper respiratory tract infection
  • Headache
  • Diarrhea
  • Nasopharyngitis (inflammation of the throat and nasal passages)

How to use Tnib 11mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 11mg Tnib Extended-Release tablet whole; avoid crushing, chewing, or breaking it. While consumption with or without food is acceptable, consistent daily timing is recommended.

How Tnib 11mg Tablet ER works:

Extended-release Tnib 11mg tablets function as a Janus kinase inhibitor, suppressing Janus kinase enzyme activity. This consequently reduces immune system responsiveness and inflammatory processes characteristic of rheumatic conditions and ulcerative colitis.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse interactions between alcohol and Tnib 11mg Extended-Release tablets.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Tnib 11mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Tnib 11mg tablets are likely not safe for use while breastfeeding. Preliminary human data indicate potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Tnib 11mg Extended-Release tablets.

KidneyKidneyCAUTION

Extended-release Tnib 11mg tablets require careful administration in individuals with advanced renal impairment. Dosage modification for Tnib 11mg extended-release tablets may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Individuals with severe hepatic impairment should exercise caution when using Tnib 11mg Extended-Release Tablets. Dosage modification of Tnib 11mg Extended-Release Tablets may be necessary. Physician consultation is advised.

What if you forget to take Tnib 11mg Tablet ER :

Should you forget to take a Tnib 11mg Extended-Release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Tnib 11mg Tablet ER

LabelValue
Chemical Type Pyrrolopyrimidine compound
Developing Habits No.
Type of Treatment Pain Relief Medications
Action Category JAK inhibitors

FAQs on Tnib 11mg Tablet ER

Tell your doctor about any liver problems before starting Tnib 11mg Tablet ER. This medication may raise liver enzyme levels in some individuals, so your liver function should be checked beforehand. While Tnib 11mg Tablet ER can be used in patients with mild to moderate liver impairment, it's contraindicated in those with severe impairment.
Taking Tnib 11mg Extended-Release Tablets may raise your risk of certain cancers, such as lymphoma and skin cancer, by impacting your immune system. Tell your doctor if you have or have ever had cancer.
Tnib 11mg Extended-Release tablets treat moderate to severe rheumatoid arthritis, a joint inflammatory disease. This medication is indicated when prior treatments proved ineffective or unsuitable. Alternatively, it may be used earlier if initial drug therapies fail to provide adequate relief. Tnib 11mg ER can be administered alone or in conjunction with other medications, including methotrexate.
You may not feel the full benefit of Tnib 11mg Extended-Release Tablets for 3 to 6 months, though some improvement may be noticed within 2 to 8 weeks.
Before and during treatment with Tnib 11mg Tablet ER, blood tests may be necessary to monitor for anemia, neutropenia, lymphopenia, high cholesterol, and elevated liver enzymes. These tests help assess the drug's effects and detect potential problems. Your doctor might also recommend a tuberculosis test beforehand, as Tnib 11mg Tablet ER could worsen an existing infection.
Tnib 11mg Tablet ER impacts the immune system, potentially lowering infection resistance and raising the risk of severe infections, such as tuberculosis. These could include life-threatening, systemic fungal, bacterial, or viral infections, requiring hospitalization.
Combining tocilizumab and Tnib 11mg Tablet ER is not recommended. Tnib 11mg Tablet ER's effect on the immune system means it shouldn't be used with other immunosuppressants. Concurrent use significantly raises the infection risk and potential for serious complications.
Tnib 11mg Tablet ER
501
MRP 580
13% off